Published in Nat Struct Mol Biol on July 29, 2007
Linking folding and binding. Curr Opin Struct Biol (2009) 5.19
Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci U S A (2008) 3.08
Intrinsically disordered proteins in cellular signalling and regulation. Nat Rev Mol Cell Biol (2015) 2.69
Dynamic equilibrium engagement of a polyvalent ligand with a single-site receptor. Proc Natl Acad Sci U S A (2008) 2.00
Biophysical characterization of intrinsically disordered proteins. Curr Opin Struct Biol (2009) 1.98
Expanding the proteome: disordered and alternatively folded proteins. Q Rev Biophys (2011) 1.60
Gating of the CFTR Cl- channel by ATP-driven nucleotide-binding domain dimerisation. J Physiol (2009) 1.58
Regulation of cell division by intrinsically unstructured proteins: intrinsic flexibility, modularity, and signaling conduits. Biochemistry (2008) 1.50
Modifications of superoxide dismutase (SOD1) in human erythrocytes: a possible role in amyotrophic lateral sclerosis. J Biol Chem (2009) 1.46
Cooperative assembly and misfolding of CFTR domains in vivo. Mol Biol Cell (2009) 1.31
Assemblages: functional units formed by cellular phase separation. J Cell Biol (2014) 1.30
Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis. Protein Sci (2010) 1.28
Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide-binding domain 1. Protein Sci (2010) 1.25
Assembly and misassembly of cystic fibrosis transmembrane conductance regulator: folding defects caused by deletion of F508 occur before and after the calnexin-dependent association of membrane spanning domain (MSD) 1 and MSD2. Mol Biol Cell (2008) 1.23
ATP-independent CFTR channel gating and allosteric modulation by phosphorylation. Proc Natl Acad Sci U S A (2010) 1.19
Physiology of epithelial chloride and fluid secretion. Cold Spring Harb Perspect Med (2012) 1.16
Building an understanding of cystic fibrosis on the foundation of ABC transporter structures. J Bioenerg Biomembr (2007) 1.14
Direct sensing of intracellular pH by the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel. J Biol Chem (2009) 1.13
NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR. EMBO J (2009) 1.12
Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding. Nucleic Acids Res (2012) 1.10
Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs). Chem Rev (2014) 1.10
Slc26a9 is inhibited by the R-region of the cystic fibrosis transmembrane conductance regulator via the STAS domain. J Biol Chem (2009) 1.08
Regulatory R region of the CFTR chloride channel is a dynamic integrator of phospho-dependent intra- and intermolecular interactions. Proc Natl Acad Sci U S A (2013) 1.06
Relationship between nucleotide binding and ion channel gating in cystic fibrosis transmembrane conductance regulator. J Physiol (2009) 1.06
The cystic fibrosis transmembrane conductance regulator (CFTR): three-dimensional structure and localization of a channel gate. J Biol Chem (2011) 1.02
Computational studies reveal phosphorylation-dependent changes in the unstructured R domain of CFTR. J Mol Biol (2008) 1.01
The CFTR ion channel: gating, regulation, and anion permeation. Cold Spring Harb Perspect Med (2013) 1.00
The role of solution NMR in the structure determinations of VDAC-1 and other membrane proteins. Curr Opin Struct Biol (2009) 1.00
Effect of Src kinase phosphorylation on disordered C-terminal domain of N-methyl-D-aspartic acid (NMDA) receptor subunit GluN2B protein. J Biol Chem (2011) 0.98
Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases. Chem Rev (2014) 0.98
Three-dimensional reconstruction of human cystic fibrosis transmembrane conductance regulator chloride channel revealed an ellipsoidal structure with orifices beneath the putative transmembrane domain. J Biol Chem (2008) 0.97
Regulation of CFTR trafficking by its R domain. J Biol Chem (2008) 0.95
Effects of molecular crowding on the dynamics of intrinsically disordered proteins. PLoS One (2012) 0.93
Modeling the conformational changes underlying channel opening in CFTR. PLoS One (2013) 0.92
Regulatory domain phosphorylation to distinguish the mechanistic basis underlying acute CFTR modulators. Am J Physiol Lung Cell Mol Physiol (2011) 0.91
Nonequilibrium gating of CFTR on an equilibrium theme. Physiology (Bethesda) (2012) 0.91
Functional Rescue of F508del-CFTR Using Small Molecule Correctors. Front Pharmacol (2012) 0.90
Phosphorylation-dependent 14-3-3 protein interactions regulate CFTR biogenesis. Mol Biol Cell (2012) 0.90
Polycation-π interactions are a driving force for molecular recognition by an intrinsically disordered oncoprotein family. PLoS Comput Biol (2013) 0.89
The impact of small molecule binding on the energy landscape of the intrinsically disordered protein C-myc. PLoS One (2012) 0.89
Conformational changes relevant to channel activity and folding within the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (2012) 0.89
Allosteric coupling between the intracellular coupling helix 4 and regulatory sites of the first nucleotide-binding domain of CFTR. PLoS One (2013) 0.89
Modulation of Intrinsically Disordered Protein Function by Post-translational Modifications. J Biol Chem (2016) 0.89
Backbone dynamics of the 18.5 kDa isoform of myelin basic protein reveals transient alpha-helices and a calmodulin-binding site. Biophys J (2008) 0.88
Cystic fibrosis transmembrane conductance regulator (ABCC7) structure. Cold Spring Harb Perspect Med (2013) 0.87
Structural changes of CFTR R region upon phosphorylation: a plastic platform for intramolecular and intermolecular interactions. FEBS J (2013) 0.86
Regulation of ABC transporter function via phosphorylation by protein kinases. Curr Pharm Biotechnol (2011) 0.86
Phenotype-optimized sequence ensembles substantially improve prediction of disease-causing mutation in cystic fibrosis. Hum Mutat (2012) 0.85
State-dependent regulation of cystic fibrosis transmembrane conductance regulator (CFTR) gating by a high affinity Fe3+ bridge between the regulatory domain and cytoplasmic loop 3. J Biol Chem (2010) 0.85
Microsecond molecular dynamics simulations of intrinsically disordered proteins involved in the oxidative stress response. PLoS One (2011) 0.85
Regulation of the cystic fibrosis transmembrane conductance regulator anion channel by tyrosine phosphorylation. FASEB J (2015) 0.84
A truncated CFTR protein rescues endogenous DeltaF508-CFTR and corrects chloride transport in mice. FASEB J (2009) 0.84
Competitive binding between dynamic p53 transactivation subdomains to human MDM2 protein: implications for regulating the p53·MDM2/MDMX interaction. J Biol Chem (2012) 0.84
Structured States of Disordered Proteins from Genomic Sequences. Cell (2016) 0.83
Dynamics intrinsic to cystic fibrosis transmembrane conductance regulator function and stability. Cold Spring Harb Perspect Med (2013) 0.83
Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase. J Biol Chem (2014) 0.83
Cystic fibrosis transmembrane conductance regulator with a shortened R domain rescues the intestinal phenotype of CFTR-/- mice. Proc Natl Acad Sci U S A (2011) 0.83
Average conformations determined from PRE data provide high-resolution maps of transient tertiary interactions in disordered proteins. Biophys J (2013) 0.83
Dynamic Protein Interaction Networks and New Structural Paradigms in Signaling. Chem Rev (2016) 0.82
Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators. Front Mol Biosci (2014) 0.82
Characterization of the interaction between HMGB1 and H3-a possible means of positioning HMGB1 in chromatin. Nucleic Acids Res (2013) 0.82
CFTR-SLC26 transporter interactions in epithelia. Biophys Rev (2012) 0.82
Unraveling a phosphorylation event in a folded protein by NMR spectroscopy: phosphorylation of the Pin1 WW domain by PKA. J Biomol NMR (2013) 0.81
Mechanism and synergism in epithelial fluid and electrolyte secretion. Pflugers Arch (2013) 0.80
Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications. Curr Pharm Des (2013) 0.80
The inhibition mechanism of non-phosphorylated Ser768 in the regulatory domain of cystic fibrosis transmembrane conductance regulator. J Biol Chem (2010) 0.80
The cystic fibrosis transmembrane conductance regulator is an extracellular chloride sensor. Pflugers Arch (2014) 0.79
Transcriptional repressor domain of MBD1 is intrinsically disordered and interacts with its binding partners in a selective manner. Sci Rep (2014) 0.79
CLC anion channel regulatory phosphorylation and conserved signal transduction domains. Biophys J (2012) 0.79
Origin and evolution of the cystic fibrosis transmembrane regulator protein R domain. Gene (2013) 0.79
Structural models of CFTR-AMPK and CFTR-PKA interactions: R-domain flexibility is a key factor in CFTR regulation. J Mol Model (2011) 0.79
CFTR is a mechanosensitive anion channel: a real stretch? Cellscience (2010) 0.79
Folding and rescue of a cystic fibrosis transmembrane conductance regulator trafficking mutant identified using human-murine chimeric proteins. J Biol Chem (2010) 0.78
Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic Loop. J Biol Chem (2015) 0.78
CFTR: A New Horizon in the Pathomechanism and Treatment of Pancreatitis. Rev Physiol Biochem Pharmacol (2016) 0.78
Development of CFTR Structure. Front Pharmacol (2012) 0.77
Phosphorylation-dependent changes in nucleotide binding, conformation, and dynamics of the first nucleotide binding domain (NBD1) of the sulfonylurea receptor 2B (SUR2B). J Biol Chem (2015) 0.77
Influence of the O-phosphorylation of serine, threonine and tyrosine in proteins on the amidic ¹⁵N chemical shielding anisotropy tensors. J Biomol NMR (2012) 0.76
Introduction to section IV: biophysical methods to approach CFTR structure. Methods Mol Biol (2011) 0.76
The cytoplasmic domain of the T-cell receptor zeta subunit does not form disordered dimers. J Mol Biol (2013) 0.76
Regulation of activation and processing of the cystic fibrosis transmembrane conductance regulator (CFTR) by a complex electrostatic interaction between the regulatory domain and cytoplasmic loop 3. J Biol Chem (2012) 0.76
Trafficking and function of the cystic fibrosis transmembrane conductance regulator: a complex network of posttranslational modifications. Am J Physiol Lung Cell Mol Physiol (2016) 0.75
Synergy of cAMP and calcium signaling pathways in CFTR regulation. Proc Natl Acad Sci U S A (2017) 0.75
Attenuation of Phosphorylation-dependent Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Disease-causing Mutations at the Transmission Interface. J Biol Chem (2016) 0.75
Development and characterization of synthetic antibodies binding to the cystic fibrosis conductance regulator. MAbs (2016) 0.75
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science (1989) 40.22
NMR View: A computer program for the visualization and analysis of NMR data. J Biomol NMR (1994) 22.42
Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry (1994) 13.94
Protein modules and signalling networks. Nature (1995) 12.53
Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol (1999) 11.38
Structure of a bacterial multidrug ABC transporter. Nature (2006) 7.76
Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature (2001) 7.31
Sequence complexity of disordered protein. Proteins (2001) 6.97
Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol (2002) 6.53
Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol (2002) 5.64
ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol Cell (2002) 4.79
Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell (1991) 3.75
Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation. Protein Sci (2006) 3.73
Intrinsic protein disorder in complete genomes. Genome Inform Ser Workshop Genome Inform (2000) 3.47
Gating of CFTR by the STAS domain of SLC26 transporters. Nat Cell Biol (2004) 3.43
Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J (2003) 3.35
Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes. PLoS Comput Biol (2006) 3.23
Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry (2005) 2.94
Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol Rev (1999) 2.89
Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J Biol Chem (1993) 2.85
Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J Biol Chem (2004) 2.66
Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region. Science (2005) 2.47
Preformed structural elements feature in partner recognition by intrinsically unstructured proteins. J Mol Biol (2004) 2.44
Side chain and backbone contributions of Phe508 to CFTR folding. Nat Struct Mol Biol (2004) 2.43
Phosphorylation of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1992) 2.28
CFTR chloride channel regulation by an interdomain interaction. Science (1999) 2.09
In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer. EMBO J (2006) 2.04
Severed channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic domains. J Gen Physiol (2000) 1.81
Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by negative charge in the R domain. J Biol Chem (1993) 1.80
Structural and dynamical properties of a denatured protein. Heteronuclear 3D NMR experiments and theoretical simulations of lysozyme in 8 M urea. Biochemistry (1997) 1.75
Stimulation of CFTR activity by its phosphorylated R domain. Nature (1997) 1.68
CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am J Physiol (1997) 1.57
Nuclear magnetic resonance methods for elucidation of structure and dynamics in disordered states. Methods Enzymol (2001) 1.50
Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry. Protein Sci (1997) 1.40
Multidimensional NMR methods for protein structure determination. IUBMB Life (2001) 1.38
Phosphorylation by cAMP-dependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator. Biochemistry (1994) 1.32
A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution. Proc Natl Acad Sci U S A (2000) 1.32
Random-coil chemical shifts of phosphorylated amino acids. J Biomol NMR (1999) 1.29
Preferential phosphorylation of R-domain Serine 768 dampens activation of CFTR channels by PKA. J Gen Physiol (2005) 1.22
Effect of phosphorylation on alpha-helix stability as a function of position. Biochemistry (2002) 1.20
Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain. J Gen Physiol (2004) 1.16
Characterization of the cystic fibrosis transmembrane conductance regulator in a colonocyte cell line. Proc Natl Acad Sci U S A (1992) 1.11
Function of the R domain in the cystic fibrosis transmembrane conductance regulator chloride channel. J Biol Chem (1997) 1.10
Dibasic phosphorylation sites in the R domain of CFTR have stimulatory and inhibitory effects on channel activation. Am J Physiol Cell Physiol (2004) 1.06
Identification of protein kinase A phosphorylation sites on NBD1 and R domains of CFTR using electrospray mass spectrometry with selective phosphate ion monitoring. Protein Sci (1996) 0.98
Cystic fibrosis transmembrane conductance regulator Cl- channels with R domain deletions and translocations show phosphorylation-dependent and -independent activity. J Biol Chem (2000) 0.96
A short segment of the R domain of cystic fibrosis transmembrane conductance regulator contains channel stimulatory and inhibitory activities that are separable by sequence modification. J Biol Chem (2002) 0.95
Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain. Biochem J (2004) 0.91
ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol Cell (2002) 4.79
Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation. Protein Sci (2006) 3.73
Gating of CFTR by the STAS domain of SLC26 transporters. Nat Cell Biol (2004) 3.43
Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J (2003) 3.35
Isotope labeling strategies for the study of high-molecular-weight proteins by solution NMR spectroscopy. Nat Protoc (2006) 3.14
The phage lambda major tail protein structure reveals a common evolution for long-tailed phages and the type VI bacterial secretion system. Proc Natl Acad Sci U S A (2009) 3.03
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet (2013) 2.91
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol (2009) 2.70
Atomic-level characterization of disordered protein ensembles. Curr Opin Struct Biol (2007) 2.65
Cooperative, ATP-dependent association of the nucleotide binding cassettes during the catalytic cycle of ATP-binding cassette transporters. J Biol Chem (2002) 2.64
Endoproteolytic activity of the proteasome. Science (2002) 2.56
Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. Cell (2007) 2.53
Side chain and backbone contributions of Phe508 to CFTR folding. Nat Struct Mol Biol (2004) 2.43
Solution structure and dynamics of the outer membrane enzyme PagP by NMR. Proc Natl Acad Sci U S A (2002) 2.39
Structure/function implications in a dynamic complex of the intrinsically disordered Sic1 with the Cdc4 subunit of an SCF ubiquitin ligase. Structure (2010) 2.33
Protein dynamics and conformational disorder in molecular recognition. J Mol Recognit (2010) 2.31
ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome. Mol Cell (2006) 2.26
A molecular mechanism for aberrant CFTR-dependent HCO(3)(-) transport in cystic fibrosis. EMBO J (2002) 2.11
Dynamic equilibrium engagement of a polyvalent ligand with a single-site receptor. Proc Natl Acad Sci U S A (2008) 2.00
Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation. Chem Biol (2008) 1.97
Solution NMR-derived global fold of a monomeric 82-kDa enzyme. Proc Natl Acad Sci U S A (2005) 1.92
Structural diversity in free and bound states of intrinsically disordered protein phosphatase 1 regulators. Structure (2010) 1.89
A protein sequence that can encode native structure by disfavoring alternate conformations. Nat Struct Biol (2002) 1.85
Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences. Cell (2012) 1.81
Coupling modes and stoichiometry of Cl-/HCO3- exchange by slc26a3 and slc26a6. J Gen Physiol (2006) 1.73
Sequence determinants of compaction in intrinsically disordered proteins. Biophys J (2010) 1.66
Probing slow dynamics in high molecular weight proteins by methyl-TROSY NMR spectroscopy: application to a 723-residue enzyme. J Am Chem Soc (2004) 1.65
A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J Biol Chem (2005) 1.65
Polyelectrostatic interactions of disordered ligands suggest a physical basis for ultrasensitivity. Proc Natl Acad Sci U S A (2007) 1.65
15N NMR spin relaxation dispersion study of the molecular crowding effects on protein folding under native conditions. J Am Chem Soc (2006) 1.60
Slc26a6 regulates CFTR activity in vivo to determine pancreatic duct HCO3- secretion: relevance to cystic fibrosis. EMBO J (2006) 1.56
The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. J Biol Chem (2010) 1.55
The energetic cost of domain reorientation in maltose-binding protein as studied by NMR and fluorescence spectroscopy. Proc Natl Acad Sci U S A (2003) 1.51
Congenital chloride-losing diarrhea causing mutations in the STAS domain result in misfolding and mistrafficking of SLC26A3. J Biol Chem (2008) 1.43
Distribution of molecular size within an unfolded state ensemble using small-angle X-ray scattering and pulse field gradient NMR techniques. J Mol Biol (2002) 1.41
Uncoupling retro-translocation and degradation in the ER-associated degradation of a soluble protein. EMBO J (2004) 1.38
Regulation of Nedd4-2 self-ubiquitination and stability by a PY motif located within its HECT-domain. Biochem J (2008) 1.36
Structure and disorder in an unfolded state under nondenaturing conditions from ensemble models consistent with a large number of experimental restraints. J Mol Biol (2009) 1.35
A change in conformational dynamics underlies the activation of Eph receptor tyrosine kinases. EMBO J (2006) 1.30
Dynamic control of cystic fibrosis transmembrane conductance regulator Cl(-)/HCO3(-) selectivity by external Cl(-). J Biol Chem (2004) 1.28
Identification of a collapsed intermediate with non-native long-range interactions on the folding pathway of a pair of Fyn SH3 domain mutants by NMR relaxation dispersion spectroscopy. J Mol Biol (2006) 1.26
Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. Proc Natl Acad Sci U S A (2002) 1.26
Improved structural characterizations of the drkN SH3 domain unfolded state suggest a compact ensemble with native-like and non-native structure. J Mol Biol (2007) 1.25
The torsin-family AAA+ protein OOC-5 contains a critical disulfide adjacent to Sensor-II that couples redox state to nucleotide binding. Mol Biol Cell (2008) 1.25
Structural determinants for high-affinity binding in a Nedd4 WW3* domain-Comm PY motif complex. Structure (2006) 1.24
Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator. J Biol Chem (2003) 1.23
IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway. J Clin Invest (2011) 1.18
Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening. J Comput Aided Mol Des (2010) 1.17
The primary folding defect and rescue of ΔF508 CFTR emerge during translation of the mutant domain. PLoS One (2010) 1.17
Composite low affinity interactions dictate recognition of the cyclin-dependent kinase inhibitor Sic1 by the SCFCdc4 ubiquitin ligase. Proc Natl Acad Sci U S A (2012) 1.15
Affinity and specificity of interactions between Nedd4 isoforms and the epithelial Na+ channel. J Biol Chem (2003) 1.15
Conformational remodeling of proteasomal substrates by PA700, the 19 S regulatory complex of the 26 S proteasome. J Biol Chem (2002) 1.15
A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome. EMBO J (2002) 1.15
Building an understanding of cystic fibrosis on the foundation of ABC transporter structures. J Bioenerg Biomembr (2007) 1.14
Probing the diverse landscape of protein flexibility and binding. Curr Opin Struct Biol (2012) 1.14
pE-DB: a database of structural ensembles of intrinsically disordered and of unfolded proteins. Nucleic Acids Res (2013) 1.13
NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR. EMBO J (2009) 1.12
Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs. Cancer Res (2007) 1.11
Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding. Nucleic Acids Res (2012) 1.10
Site-specific contributions to the pH dependence of protein stability. Proc Natl Acad Sci U S A (2003) 1.09
Aromatic and methyl NOEs highlight hydrophobic clustering in the unfolded state of an SH3 domain. Biochemistry (2003) 1.09
Coupling of tandem Smad ubiquitination regulatory factor (Smurf) WW domains modulates target specificity. Proc Natl Acad Sci U S A (2010) 1.08
Comparison of Secondary Structure Formation Using 10 Different Force Fields in Microsecond Molecular Dynamics Simulations. J Chem Theory Comput (2012) 1.07
The cystic fibrosis transmembrane conductance regulator interacts with and regulates the activity of the HCO3- salvage transporter human Na+-HCO3- cotransport isoform 3. J Biol Chem (2002) 1.06
Regulatory R region of the CFTR chloride channel is a dynamic integrator of phospho-dependent intra- and intermolecular interactions. Proc Natl Acad Sci U S A (2013) 1.06
ESCRT-dependent targeting of plasma membrane localized KCa3.1 to the lysosomes. Am J Physiol Cell Physiol (2010) 1.06
Aggresome formation. Methods Mol Biol (2005) 1.06
The solution structure of the C-terminal Ig-like domain of the bacteriophage λ tail tube protein. J Mol Biol (2010) 1.04
Regulatory interaction between CFTR and the SLC26 transporters. Novartis Found Symp (2006) 1.04
A unique redox-sensing sensor II motif in TorsinA plays a critical role in nucleotide and partner binding. J Biol Chem (2010) 1.04
Measurement of side-chain carboxyl pK(a) values of glutamate and aspartate residues in an unfolded protein by multinuclear NMR spectroscopy. J Am Chem Soc (2002) 1.03
Interaction of the eukaryotic initiation factor 4E with 4E-BP2 at a dynamic bipartite interface. Structure (2013) 1.02
Calculation of residual dipolar couplings from disordered state ensembles using local alignment. J Am Chem Soc (2008) 1.02
Cooperative interactions and a non-native buried Trp in the unfolded state of an SH3 domain. J Mol Biol (2002) 1.01
An expanded WW domain recognition motif revealed by the interaction between Smad7 and the E3 ubiquitin ligase Smurf2. J Biol Chem (2006) 1.00
Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR. J Physiol (2014) 1.00
HNH proteins are a widespread component of phage DNA packaging machines. Proc Natl Acad Sci U S A (2014) 0.98
Ensemble modeling of protein disordered states: experimental restraint contributions and validation. Proteins (2011) 0.98
Differential dynamic engagement within 24 SH3 domain: peptide complexes revealed by co-linear chemical shift perturbation analysis. PLoS One (2012) 0.97
Solution-phase chelators for suppressing nonspecific protein-metal interactions in electrospray mass spectrometry. Anal Chem (2009) 0.96
The protein gp74 from the bacteriophage HK97 functions as a HNH endonuclease. Protein Sci (2012) 0.95
Characterization of disordered proteins with ENSEMBLE. Bioinformatics (2012) 0.95
Structural, functional, and bioinformatic studies demonstrate the crucial role of an extended peptide binding site for the SH3 domain of yeast Abp1p. J Biol Chem (2009) 0.94
Activation of the epithelial sodium channel (ENaC) by the alkaline protease from Pseudomonas aeruginosa. J Biol Chem (2012) 0.94
Effects of molecular crowding on the dynamics of intrinsically disordered proteins. PLoS One (2012) 0.93
Nucleotide binding domain interactions during the mechanochemical reaction cycle of ATP-binding cassette transporters. J Bioenerg Biomembr (2005) 0.93
Calcium-induced folding and stabilization of the Pseudomonas aeruginosa alkaline protease. J Biol Chem (2011) 0.93